Fundamental Analysis of Hillstream Biopharma Inc - Growth / Value Index


HILS - Valuation Highlights

Valuation Analysis

   Price to Book Ratio is 0.766 indicating that it is undervalued.
   Book Value in last 3 years is trending up
   Tsr Value Index - Very Poor Score of 14.29
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -0.369 -0.306 73.96 %
Price to Book 0.766 0.467 184.51 % 2.27
Price to Sales 0 0 0 %
Enterprise Value to EBITDA Multiple 0.282 0.570 116.50 %


HILS - Profitability Highlights

Profitability Analysis

   Steady Growth in EPS for last four quarters
   Tsr Profitability Index - Very Poor Score of 5.00
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -207.67 -152.84 0 % -103.60
Return On Asset -159.05 -126.68 64.31 % -57.47
Net Profit Margin 0 0 0 % 0
Operating Profit Margin 0 0 0 % 0
EBITDA Margin 0 0 0 % 0


Highlights
Market Cap4057.42 K
Enterprise Value-2453.11 K
Price/Book TTM0.766
Outstanding Share17602.70 K
Float/ Outstanding Share65.09%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score3.00
Altman Z Score-777.60
Sloan Ratio-0.286
Peter Lynch Fair Value0


HILS - Growth Highlights

Growth Analysis

   Quarterly sales in last 5 years is trending up
   Steady increase in Total Assets for last 3 Years
   Quarterly sales in last 5 Quarter is trending down
   Annual sales in last 3 years is trending down
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue NA % %
Gross Profit NA % %
EBITDA -8690.50 K 400.37 % 21.97 %
Net Profit -8591.78 K 283.99 % 22.11 %
EPS -0.625 283.99 % NA


HILS - Stability Highlights

Stability Analysis

   Tsr Stability Index - Good Score of 76.79
   Company is Debt Free
   Net Debt zero balance-sheet with high liquidity
   Cash ratio of 5.69
   Company financial liquidity has improved
   Altman Z Score of -777.60 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -5.31
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0 0 % 0
Cash Ratio 5.69 591712 %
Quick Ratio 0 0 % 2.25
Shareholders Equity 82.88 111.00 %
Debt to EBITDA 0 0 %


Historical Valuation Ratios of Hillstream Biopharma Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Hillstream Biopharma Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Hillstream Biopharma Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Hillstream Biopharma Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)